tiprankstipranks
BioCryst sees FY25 ORLADEYO revenue between $515M-$535M
The Fly

BioCryst sees FY25 ORLADEYO revenue between $515M-$535M

The company expects full year 2025 global net ORLADEYO revenue will be between $515 million and $535 million.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App